Sepp-Lorenzino Laura

EDGAR CIK 0001777421

Intellia Therapeutics, Inc. - NTLA

  1. Manufacturing
  2. Chemicals
  3. In Vitro & In Vivo Diagnostic Substances
Officer
EVP, Chief Scientific Officer
Direct Buys
0
$0
0 Shares
Direct Sells
2
($228,654)
-7,807 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
01/08/2024
10b5-1
01/10/2024
Sell
-2,275 @ $28.87
 ($65,682) 43,927 (-4.92%) Direct
01/03/2024
01/05/2024
Sell
-5,532 @ $29.46
 ($162,973) 46,202 (-10.69%) Direct